Elizabethkingia

Elizabethkingia is a genus of Gram-negative bacteria belonging to the family Weeksellaceae. This genus is known for its clinical significance, particularly in causing infections in humans. The genus was named in honor of the American bacteriologist Elizabeth O. King.

Taxonomy

The genus Elizabethkingia was first described in 2005, and it includes several species that were previously classified under different genera. The most notable species include Elizabethkingia anophelis, Elizabethkingia meningoseptica, and Elizabethkingia miricola.

Morphology

Elizabethkingia species are non-motile, rod-shaped bacteria. They are characterized by their ability to form yellow-pigmented colonies on agar plates. These bacteria are aerobic and do not form spores.

Pathogenicity

Elizabethkingia species are opportunistic pathogens, primarily affecting individuals with weakened immune systems. They are known to cause a range of infections, including bacteremia, pneumonia, meningitis, and endocarditis.

Elizabethkingia meningoseptica

Elizabethkingia meningoseptica is the most well-known species within the genus. It is associated with neonatal meningitis and has been isolated from various environmental sources, including water and soil. This species is particularly resistant to many common antibiotics, making infections difficult to treat.

Elizabethkingia anophelis

Elizabethkingia anophelis was first isolated from the midgut of the Anopheles gambiae mosquito. It has been implicated in several outbreaks of severe infections in humans, particularly in healthcare settings. Like E. meningoseptica, it exhibits resistance to multiple antibiotics.

Epidemiology

Infections caused by Elizabethkingia are relatively rare but can be severe. Outbreaks have been reported in various parts of the world, often in hospital settings. The bacteria are found in a variety of environments, including water systems, which can serve as a reservoir for infection.

Diagnosis

Diagnosis of Elizabethkingia infections involves the isolation and identification of the bacteria from clinical specimens. This is typically done using culture techniques and molecular methods such as polymerase chain reaction (PCR).

Treatment

Treatment of Elizabethkingia infections is challenging due to the bacteria's intrinsic resistance to many antibiotics. Empirical therapy often includes the use of fluoroquinolones, trimethoprim/sulfamethoxazole, and piperacillin/tazobactam. However, susceptibility testing is crucial to guide appropriate therapy.

Prevention

Preventing Elizabethkingia infections involves strict adherence to infection control practices, particularly in healthcare settings. This includes proper hand hygiene, sterilization of medical equipment, and monitoring of water systems to prevent contamination.

Research

Ongoing research is focused on understanding the mechanisms of antibiotic resistance in Elizabethkingia and developing new therapeutic strategies. Studies are also exploring the ecological role of these bacteria and their interactions with host organisms.

See also

• Gram-negative bacteria
• Opportunistic infection
• Antibiotic resistance